Image de couverture de livre

Evaluation of Larger Side‐Group Functionalities and the Side/End‐Group Interplay in Ritonavir‐Like Inhibitors of CYP3A4

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Eric R. Samuels, Irina F. Sevrioukova
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Chemical Biology & Drug Design
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities
par: Yu Jiang, et autres
Publié: (2025)

Procyanidin Alleviates Diabetic Retinopathy by Activating the Expression of Activating Transcription Factor 1 Expression to Upregulate Synoviolin 1 and Inhibit the High Mobility Group Box 1/Toll‐Like Receptor 4 Pathway
par: Limin Zheng, et autres
Publié: (2025)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
par: Kalyani R. Thombre, et autres
Publié: (2026)

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
par: Shiying Zhang, et autres
Publié: (2025)

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology
par: Rameshwar S. Cheke, et autres
Publié: (2025)

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors
par: Rui Pereira, et autres
Publié: (2026)

Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
par: Hualiang Shen, et autres
Publié: (2025)

Design and Synthesis of Holu‐7, a Quinazolinone Derivative With an Active Stereo Geometry and Polar 2,4‐Dihydroxyphenyl Group, as a Selective Anticancer Agent
par: Kuo‐Chu Lai, et autres
Publié: (2025)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
par: Yi‐Fan Zhang, et autres
Publié: (2024)

Chromone Derivatives as a Novel NOX4 Inhibitor: Design, Synthesis, and Regulation of ROS in Renal Fibroblast
par: Siming Wu, et autres
Publié: (2024)

Antiproliferative Activity and Target Analysis of 18β‐Glycyrrhetinic Acid Derivatives Modified With α, β‐Unsaturated Carbonyl Groups
par: Chenmeng Xu, et autres
Publié: (2025)

An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐induced skin inflammation by targeting the CYP19A1
par: Xiaoyan Lu, et autres
Publié: (2024)

NMC‐4 Ameliorates Depression‐Like Behavior and Neuroinflammation Caused by Chronic Unpredictable Mild Stress
par: Yawen Chen, et autres
Publié: (2024)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
par: Ayşen Işık, et autres
Publié: (2024)

Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis: A Computational and Experimental Study
par: Mariana Sant’Anna Pereira Nicolau, et autres
Publié: (2025)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
par: Jingting Zeng, et autres
Publié: (2025)

Comprehensive Analysis of NADH:Ubiquinone Oxidoreductase Subunit B3 in Gynecological Tumors and Identification of Its Natural Inhibitor Wedelolactone
par: Huiping Li, et autres
Publié: (2024)

Semisynthetic p‐Coumaric Acid Derivatives as Lead Dual Inhibitors Against DPP‐IV and GSK‐3β for Antidiabetic Therapy
par: Heberth de Paula, et autres
Publié: (2024)

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent
par: Qingxin Liu, et autres
Publié: (2025)

A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors
par: Deniz A. Anakök, et autres
Publié: (2025)

Spalt‐Like Transcription Factor 4 Mediates Fatty Acid Oxidation to Foster 5‐Fluorouracil Resistance in Gastric Cancer Cells
par: Yong Zhu, et autres
Publié: (2025)

A Comprehensive Review on the Advancements of Dual COX‐2/5‐LOX Inhibitors as Anti‐Inflammatory Drugs
par: Neetu Agrawal
Publié: (2025)

Spacered With Tetrazole Oleanolic and Ursolic Indolo‐Acids Are Strong Inhibitors of α‐Glucosidase
par: Anastasiya V. Petrova, et autres
Publié: (2025)

Computationally Driven Exploration of Novel bis‐Thiadiazole Sulfonamides as Alzheimer's Enzyme Inhibitors: A DFT and Kinetic Perspective
par: Farman Ullah, et autres
Publié: (2025)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
par: Vladislav Lobanov, et autres
Publié: (2025)

Identification and Biological Evaluation of ( 4 H ‐Thieno[3,2‐ b ]indol‐3‐yl)methanol as a Tumoricidal Scaffold for an Antineoplastic Agent
par: Shi‐Hong Zhuang, et autres
Publié: (2025)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
par: Gözde Sayar, et autres
Publié: (2026)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
par: Nurul Alam Inayatsyah, et autres
Publié: (2024)

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin
par: Ruihan Zhao, et autres
Publié: (2024)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
par: Vijaykumar D. Nimbarte, et autres
Publié: (2025)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
par: Jiayi Shen, et autres
Publié: (2024)

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
par: Chung‐Ting Kuo, et autres
Publié: (2026)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
par: Ozge Kuyrukcu Ozturk, et autres
Publié: (2026)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
par: Shreetama Bandyopadhayaya, et autres
Publié: (2025)

Biochemical and Structural Studies of Protein Tyrosine Phosphatase PTP‐PEST (PTPN12) in Search of Small Molecule Inhibitors
par: Delna Johnson, et autres
Publié: (2025)

Comment on “Integrative Analysis of Ex Vivo Studies and Microarray Reveals the Novel Inhibitor Effects of Trehalose on the Pathogenesis of Pterygium”
par: Thiago Gonçalves dos Santos Martins
Publié: (2024)

Design and Synthesis of 2‐Aminopyrazolpyrimidopyridone Derivatives as RET V 804 M and RET G 810 C Kinase Inhibitors
par: Jiayi Shen, et autres
Publié: (2025)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
par: Yihao Liu, et autres
Publié: (2026)

Identification of Potential PBP2a Inhibitors Against Methicillin‐Resistant Staphylococcus aureus via Drug Repurposing and Combination Therapy
par: Fangfang Jiao, et autres
Publié: (2025)

In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research
par: Behnaz Yazdani, et autres
Publié: (2025)